Literature DB >> 10449283

Antigen-specific cytokine response to hepatitis C virus core epitopes in HIV/hepatitis C virus-coinfected patients.

R P Woitas1, J K Rockstroh, I Beier, G Jung, B Kochan, B Matz, H H Brackmann, T Sauerbruch, U Spengler.   

Abstract

OBJECTIVE: Epidemiological data indicate that hepatitis C virus (HCV) infection runs a more rapid and severe course of disease in HIV-coinfected patients, probably because of an altered immune response.
DESIGN: We investigated whether HCV-specific cytokine responses are affected by HIV coinfection.
METHODS: Using triple colour flow cytometry on peripheral blood lymphocytes after stimulation with the four major immunodominant HCV core T cell epitopes, CT1-CT4, we determined intracytoplasmic production of IFN-gamma, IL-2, IL-4, IL-10 and CD30 expression, a putative surrogate marker of type 2 cells. Fifteen patients with asymptomatic HIV/HCV coinfection (group A), 15 patients with chronic HCV infection (group B) and 10 HIV-infected patients without hepatitis C (group C) were included in the study.
RESULTS: In group A, HCV antigens induced significantly higher IL-2 and IFN-gamma production than groups B and C (P < 0.05). Groups A and B showed a similar induction of CD30, which was significantly higher than in group C (P < 0.001). Remarkably, in group A HCV antigens induced IL-4 production in addition to IL-10 and IFN-gamma in the CD30 subset, whereas in groups B and C no IL-4 induction was observed in this T cell subset (P < 0.002).
CONCLUSION: Our data suggest that asymptomatic HIV coinfection importantly alters the HCV-specific cytokine response towards a greater production of proinflammatory type 1 cytokines. Moreover, the antiviral activity of type 1 cytokines may be modified by an increased production of type 2 cytokines in the CD30 subset. The altered cytokine pattern may contribute to the adverse natural course of hepatitis C in HIV coinfection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449283     DOI: 10.1097/00002030-199907300-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

Review 1.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 2.  Transfusion transmitted virus: A review on its molecular characteristics and role in medicine.

Authors:  M Irshad; Y K Joshi; Y Sharma; I Dhar
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

3.  HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.

Authors:  Rainer P Woitas; Uwe Petersen; Dirk Moshage; Hans H Brackmann; Bertfried Matz; Tilman Sauerbruch; Ulrich Spengler
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

Review 4.  Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations.

Authors:  Miriam Romero; Mayte Pérez-Olmeda; Javier García-Samaniego; Vicente Soriano
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 5.  HBV plus HCV, HCV plus HIV, HBV plus HIV.

Authors:  James S Park; Neeraj Saraf; Douglas T Dieterich
Journal:  Curr Gastroenterol Rep       Date:  2006-02

6.  TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.

Authors:  Stacey A Rizza; Kishore B Challagundla; Sekar Natesampillai; Gary D Bren; Jaromir Sykora; Henning Walczak; Andrew D Badley
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

7.  Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.

Authors:  Lauren E Kushner; Aaron M Wendelboe; Laura C Lazzeroni; Aarthi Chary; Mark A Winters; Anu Osinusi; Shyam Kottilil; Michael A Polis; Mark Holodniy
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.